Literature DB >> 25919803

Accuracy of Contrast-enhanced US for Differentiating Benign from Malignant Solid Small Renal Masses.

Mostafa Atri1, Leila Tabatabaeifar1, Hyun-Jung Jang1, Anthony Finelli1, Hadas Moshonov1, Michael Jewett1.   

Abstract

PURPOSE: To test the hypothesis that qualitative and quantitative features of contrast material-enhanced ultrasonography (US) can be used to differentiate benign from malignant small renal masses.
MATERIALS AND METHODS: This is an institutional review board approved, HIPAA-compliant prospective study with written informed consent. Patients with histologically characterized solid small renal masses, excluding lipid-rich angiomyolipomas, underwent qualitative contrast-enhanced US with a combination of three different US machines. A subgroup of patients underwent quantitative contrast-enhanced US. Patients received a bolus injection of 0.2 mL of contrast material for qualitative and quantitative evaluations and were followed for 3 minutes. Two radiologists independently reviewed videotaped qualitative contrast-enhanced US examinations and were blinded to the final diagnoses. Features that were evaluated included lesion vascularity relative to the adjacent cortex in the arterial phase, the presence of a capsule, homogeneity, the pattern of vascularity, and washout. One radiologist separately reviewed a subset of contrast-enhanced US examinations that were performed with all three machines. Parameters of a first-pass time intensity curve were calculated for quantitative analysis. The Mann-Whitney test was used for quantitative parameters, the χ(2) or Fisher exact test was used for qualitative parameters, and κ statistics and Fleiss methodology were used to determine interobserver and intermachine agreement.
RESULTS: The study population consisted of 91 patients (35 women and 56 men) with 94 lesions. The mean age was 62 years ± 14 (range, 21-91). Three patients had two lesions each, which were evaluated at two different sessions. There were 26 benign small renal masses (including 18 oncocytomas, seven lipid-poor angiomyolipomas, and one hemangioblastoma) and 68 malignant masses (including 41 clear cell, 20 papillary, and seven chromophobe renal cell carcinomas [RCCs[) that were 1.1-4.0 cm in diameter (mean, 2.7 cm ± 0.9). All patients underwent contrast-enhanced US on the same one machine, and 68 patients were imaged on all three machines. Vascularity was present in all lesions (n = 94) at contrast-enhanced US. Lesion hypovascularity relative to the adjacent cortex in the arterial phase was seen in only malignant lesions by both reviewers; reviewer 1 saw hypovascularity in 24 of 94 lesions (P = .0001), and reviewer 2 saw hypovascularity in 21 of 94 lesions (P = .0006), for a specificity of 100% (95% confidence interval [CI]: 84, 100). This feature had κ values of 0.91 (95%CI: 0.82, 1.00) between the two reviewers and 0.85 (95% CI: 0.72, 0.99) between the three machines. Eighteen of 20 papillary RCCs were hypovascular. Quantitative parameters of area under the receiver operating characteristics curve, peak intensity, wash-in slope of 10%-90% and 5%-45%, and washout slope of 100%-10% and 50%-10% were significantly higher in malignant renal masses (P = .018, P = .002, P = .036, P = .016, P = .001, and P = .005, respectively) than in benign lesions.
CONCLUSION: Excluding lipid-rich angiomyolipoma, hypovascularity-which has high interobserver and intermachine agreement-of solid small renal masses relative to the cortex in the arterial phase has 100% specificity (95% CI: 84, 100) for detecting malignancy, most often papillary RCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25919803     DOI: 10.1148/radiol.2015140907

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  Contrast-enhanced ultrasound of the kidneys and adrenals in children.

Authors:  Susan J Back; Patricia T Acharya; Richard D Bellah; Harris L Cohen; Kassa Darge; Annamaria Deganello; Zoltan Harkanyi; Damjana Ključevšek; Aikaterini Ntoulia; Harriet J Paltiel; Maciej Piskunowicz
Journal:  Pediatr Radiol       Date:  2021-05-12

2.  CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A multi-institutional review.

Authors:  F Cornelis; D Ambrosetti; L Rocher; L E Derchi; B Renard; P Puech; M Claudon; O Rouvière; S Ferlicot; C Roy; M Yacoub; N Grenier; J C Bernhard
Journal:  Eur Radiol       Date:  2016-06-22       Impact factor: 5.315

3.  A Pilot Clinical Study in Characterization of Malignant Renal-cell Carcinoma Subtype with Contrast-enhanced Ultrasound.

Authors:  Sandeep K Kasoji; Emily H Chang; Lee B Mullin; Wui K Chong; W Kimryn Rathmell; Paul A Dayton
Journal:  Ultrason Imaging       Date:  2016-09-22       Impact factor: 1.578

4.  Differential diagnosis of <3 cm renal tumors by ultrasonography: a rapid, quantitative, elastography self-corrected contrast-enhanced ultrasound imaging mode beyond screening.

Authors:  Di Sun; Qijie Lu; Cong Wei; Yi Li; Yuanyi Zheng; Bing Hu
Journal:  Br J Radiol       Date:  2020-06-09       Impact factor: 3.039

Review 5.  Contrast-Enhanced Ultrasound-Guided Radiofrequency Ablation of Renal Tumors.

Authors:  Dan O'Neal; Tal Cohen; Cynthia Peterson; Richard G Barr
Journal:  J Kidney Cancer VHL       Date:  2018-02-02

6.  Untargeted Contrast-Enhanced Ultrasound Versus Contrast-Enhanced Computed Tomography: A Differential Diagnostic Performance (DDP) Study for Kidney Lesions.

Authors:  Li Jin; Feng Xie
Journal:  Clinics (Sao Paulo)       Date:  2020-02-27       Impact factor: 2.365

Review 7.  Characteristics of contrast-enhanced ultrasound for diagnosis of solid clear cell renal cell carcinomas ≤4 cm: A meta-analysis.

Authors:  Yang Liu; Yanmin Kan; Jincun Zhang; Ning Li; Yihua Wang
Journal:  Cancer Med       Date:  2021-11-01       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.